login
login

Europe Daily Bulletin No. 7814

6 October 2000
Contents Publication in full By article 51 / 54
ECONOMIC INTERPENETRATION / (eu) medical

The Anglo-Norwegian group NYCOMED AMERSHAM (contrast products for radiology) is preparing to sell 10% of its stake in APBIOTECH - AMERSHAM PHARMACIA BIOTECH (laboratory equipment and products for research into biotechnology) and float it on Nasdaq. After this sale, NYCOMED will still hold a 45% stake in APBIOTECH, the remainder in the hands of PHARMACIA & UPJOHN.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION